Data / Form D filings / Tetragenetics Inc
Tetragenetics Inc: Form D filings
Tetragenetics Inc, a biotechnology company in Arlington, MA, filed 8 Form D notices with the SEC between 2009 and 2020. The latest, on September 29, 2020, reports $1 million sold of a $2 million offering to 13 investors.
Find out what Tetragenetics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 91 Mystic Street, Arlington, MA, 02474
- Phone
- (617) 500-7471
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New York
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1409403
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2020 | New notice | $2,000,000 | $1,012,497 | $987,503 | 13 | Sep 19, 2020 | sec.gov |
| Jul 19, 2018 | New notice | $2,000,000 | $809,770 | $1,190,230 | 15 | Jun 29, 2018 | sec.gov |
| Mar 1, 2017 | New notice | $2,000,000 | $1,097,072 | $902,928 | 21 | Feb 21, 2017 | sec.gov |
| Nov 24, 2015 | New notice | $1,500,000 | $336,000 | $1,164,000 | 8 | Nov 9, 2015 | sec.gov |
| Mar 9, 2015 | New notice | $1,500,000 | $338,191 | $1,161,809 | 8 | Mar 3, 2015 | sec.gov |
| Jun 5, 2013 | New notice | $800,000 | $502,000 | $298,000 | 24 | May 21, 2013 | sec.gov |
| Aug 28, 2012 | New notice | $5,000,000 | $2,474,231 | $2,525,769 | 55 | Aug 22, 2012 | sec.gov |
| Dec 7, 2009 | New notice | $490,308 | $490,308 | $0 | 9 | Nov 24, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Taron | Director | |
| Ellen Douglas Baron | Director | |
| Kevin Douglas O'Brien | Executive Officer | |
| Peter Douglas Kiener | Director | |
| Alison Douglas Taunton-Rigby | Director | |
| Robert Douglas Gailus | Director | |
| Theodore Clark | Executive Officer, Director | |
| R Douglas Kahn | Executive Officer, Director | |
| Daniel Douglas Grau | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Sep 28, 2020 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tetragenetics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.